Immunovant

+$0.31 (+3.96%) As of 6:16 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.

About IMVT

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on enabling normal lives for patients with autoimmune diseases.

CEO
Peter Salzmann
Employees
—
Headquarters
New York, New York
Founded
2018

IMVT Key Statistics

Market Cap
936.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
412.90K
High Today
$8.21
Low Today
$7.76
Open Price
$7.84
Volume
172.23K
52 Week High
$53.75
52 Week Low
$6.68

IMVT Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure